1. Parmar, H, Edwards, L, Phillips, RH, Allen, L and Lightman, SL (1987). Orchiectomy versus long-acting D-Trp-6-LHRH in advanced prostatic cancer. Brit J Urol, 59, 248
2. Senge, T, Hulshoff, T, Tunn, U, Schenck, B and Neumann, F (1978). Testosteronkonzentratien in serum nach subkapsularer orchidektomie. Urologe A, 177, 382
3. Labrie, F, Dupont, A and Belanger, A (1985). Complete androgen blockade for the treatment of prostate cancer. In: DeVita, VT Jr, Hellman, S and Rosenberg, SA (eds.). “Important Advances in Oncology 1985”. p.193. (Philadelphia: JB Lippincott Company)
4. Denis, L, Keuppens, F, Mahler, C, Debruyne, FMJ, Weil, EHJ, Lunglmayr, G, Newling, D, Robinson, MRG, Richards, B, Smith, PH and Whelman, P (1987). Long term therapy with a depot LHRH analogue (Zoladex R) in patients with advanced prostatic cancer. In: Murphy, GP, Khoury, S, Küss, R, Chatelain, R and Denis, L (eds.) “Prostate Cancer Part A: Research, Endocrine Treatment, and Histopathology”. p.221. (New York: AR Liss Inc.)
5. Denis, L (1988). Luteinizing hormone releasing hormone agonists. In: Denis, L (ed.) “Medical Management of Prostatic Cancer”. p.49. (Berlin: Springer Verlag)